Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of AGPAT2 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of AGPAT2 protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of AGPAT2 mRNA | decreases expression | 20106945
|
C110904 |
capecitabine |
AGPAT2 protein results in increased susceptibility to capecitabine | increases response to substance | 16734730
|
C039671 |
ciglitazone |
ciglitazone results in increased expression of AGPAT2 mRNA | increases expression | 16847310
|
D002995 |
Clofibric Acid |
Clofibric Acid affects the expression of AGPAT2 mRNA | affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of AGPAT2 mRNA | decreases expression | 20106945
|
C014347 |
decitabine |
decitabine results in increased expression of AGPAT2 mRNA | increases expression | 17908484
|
C056507 |
gemcitabine |
gemcitabine results in decreased expression of AGPAT2 mRNA | decreases expression | 17039268
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of AGPAT2 mRNA | affects cotreatment|decreases expression | 17183730
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of AGPAT2 mRNA | decreases expression | 16847310
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid affects the expression of AGPAT2 mRNA | affects expression | 18281256
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of AGPAT2 mRNA | increases expression | 18301758
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA | affects cotreatment|decreases expression | 19244175
|
D012643 |
Selenium |
Selenium results in increased expression of AGPAT2 mRNA | increases expression | 19244175
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of AGPAT2 mRNA | increases expression | 20106945
|
D013752 |
Tetracycline |
Tetracycline results in increased expression of AGPAT2 mRNA | increases expression | 16917069
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of AGPAT2 mRNA | affects cotreatment|decreases expression | 17183730
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA | affects cotreatment|decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.19 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.19 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.89 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.90 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.90 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.97 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.63 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.78 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.78 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.20 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.91 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.81 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.54 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.03 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 17688650 18940202 18316065 15238991 17507914 19232924 16609825 18558336 17157402 20603192 18177632 18396377 18775368 19460635 18985861 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.05 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.63 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.63 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.93 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.93 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.36 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
2.36 | 18473752 12972520 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.36 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
2.36 | 17039268 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.89 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.76 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.87 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
2.87 | 21507988 12619106 12907637 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.64 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.64 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.34 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.55 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.50 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.69 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.65 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.65 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 12621046 15668235 16354765 15340226 8697196 |
MESH:D003092 |
Colitis |
|
Selenium |
3.74 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.33 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
3.11 | 18473752 18448328 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.11 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 17141729 14669216 |
MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.77 | 17465463 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.75 | 8888407 16575769 17688650 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.75 | 19769572 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.40 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.89 | 17906064 10774834 19085960 19164858 18071297 14550746 10915739 12153990 19416960 2444490 14725611 12594235 11743745 19923254 11461765 12540782 11287661 16393943 16781746 17562736 18713872 11529661 12705907 19370779 11739529 16485898 19739265 10663392 16177239 12958197 15968718 12392966 14986274 17522070 11834606 16081117 19420014 11421492 16227642 16109766 15619225 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
11.89 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.89 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
11.89 | 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
11.89 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.07 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.73 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.01 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.68 | 9068938 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
11.23 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.23 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.23 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.87 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
ciglitazone |
5.43 | 16844232 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.09 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.98 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.36 | 15328337 17637181 15821434 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.11 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.89 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.91 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.55 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.26 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.03 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.00 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.47 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.47 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
18.47 | 16917069 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
18.47 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.42 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.86 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.09 | 8888407 18558336 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.97 | 11852909 9205823 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.35 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.35 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.65 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.18 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.57 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.46 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.97 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.97 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
10.97 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.86 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.86 | 17162251 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.39 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.34 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.29 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
14.24 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
14.24 | 19176532 18467677 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
14.24 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.69 | 16490937 16863852 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.94 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.83 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.02 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.74 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.74 | 12083418 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.14 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.89 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.89 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.59 | 16612254 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.17 | 17581917 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
8.30 | 17255318 17237260 9205823 12878042 17963957 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
8.30 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.30 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.86 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
10.86 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.60 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.59 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.29 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.41 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.86 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.86 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
9.86 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.84 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.70 | 12371664 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.05 | 18980019 19235587 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.96 | 17236224 19117987 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.97 | 18460780 18206229 17679729 19010910 19387464 18704418 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.97 | 17596541 16294345 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.43 | 18055864 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.66 | 15821434 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.19 | 8812269 |
OMIM:608594 |
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1 |
marker/mechanism |
|
| |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
4.91 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.91 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.91 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
4.91 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.62 | 12969438 16611625 12587719 19784758 19460945 16610002 11587558 19014921 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.20 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
17.78 | 15890375 9163691 18177683 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
17.78 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
17.78 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
17.78 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
17.78 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
17.78 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.71 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.71 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.15 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.23 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.97 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.56 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.56 | 6695378 20064080 18569708 18520028 20135361 20869020 18816296 17053015 20464547 |
MESH:D008175 |
Lung Neoplasms |
|
ciglitazone |
6.56 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.56 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
6.56 | 11062179 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.39 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.73 | 15318939 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.24 | 17785578 16505122 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.53 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.77 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.76 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.16 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.15 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.31 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.47 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.99 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.42 | 16882708 18608210 19010910 19157545 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.42 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.12 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.98 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.91 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
4.11 | 12972520 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.75 | 11141357 |
MESH:D009369 |
Neoplasms |
|
capecitabine |
11.75 | 16374040 |
MESH:D009369 |
Neoplasms |
|
decitabine |
11.75 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.75 | 17405874 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
4.76 | 9884423 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.41 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.24 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.17 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.10 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.83 | 18514411 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.91 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.80 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.63 | 19259094 19331143 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.35 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.72 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
5.72 | 18992248 17440100 18383843 16929163 11504793 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.22 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
5.40 | 11026799 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.86 | 15087411 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.52 | 12224865 11605937 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.52 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.18 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
16.11 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.11 | 11896295 11118676 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
16.11 | 20603192 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.69 | 17616702 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
5.38 | 10903871 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.20 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.20 | 15084515 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.51 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.21 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.36 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.70 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.80 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.84 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.84 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.06 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.71 | 3137016 11738929 1511512 15475178 14763951 16876388 11044598 17978042 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.43 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.40 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.40 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.75 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.51 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.45 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.45 | 19037991 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.48 | 16517955 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.12 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.87 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.29 | 17967635 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.20 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.49 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.07 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.07 | 17616700 19087683 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.60 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.94 | 10982225 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.88 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.96 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.57 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.22 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.41 | 17120751 |